drugset / Trial / NCT04904952
Effect of N-acetylcysteine as Add on Therapy With SSRI in Moderate to Severe OCD Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
Title: Effect of n-acetylcysteine as add-on therapy with Selective Serotonin Reuptake Inhibitors in moderate to severe Obsessive Compulsive Disorder patients. Purpose of the study: To assess the effects of the addition of n-acetylcysteine with SSRIs on the severity of symptoms in obsessive-compulsive disorder patients.
Timeline
- Start
- 2020-03-13
- Primary completion
- 2022-01-10
- Completion
- 2022-01-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | N-acetylcysteine | Small molecule | 2400 mg | — |